These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 23668745)
1. Menopausal hormone therapy: examining cardiovascular and clinical impacts of treatment. Chiu CL; Lind JM Future Cardiol; 2013 May; 9(3):427-35. PubMed ID: 23668745 [TBL] [Abstract][Full Text] [Related]
2. An update on menopausal hormone replacement therapy in women and cardiovascular disease. Valdiviezo C; Lawson S; Ouyang P Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):148-55. PubMed ID: 23422240 [TBL] [Abstract][Full Text] [Related]
3. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340 [TBL] [Abstract][Full Text] [Related]
4. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women. Stephenson K; Neuenschwander PF; Kurdowska AK Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249 [TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy (MHT): refining our understanding of MHT research, optimally applying results, and considering the future of MHT. Anagnostis EA J Pharm Pract; 2012 Jun; 25(3):324-30. PubMed ID: 22550160 [TBL] [Abstract][Full Text] [Related]
6. [Menopausal hormone treatment in 2011]. Rozenberg S; Vandromme J; Antoine C Rev Med Brux; 2011 Sep; 32(4):239-42. PubMed ID: 22034751 [TBL] [Abstract][Full Text] [Related]
7. The hormone replacement therapy (HRT) of menopause: focus on cardiovascular implications. Denti L Acta Biomed; 2010; 81 Suppl 1():73-6. PubMed ID: 20518194 [TBL] [Abstract][Full Text] [Related]
8. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
9. The Timing Hypothesis remains a valid explanation of differential cardioprotective effects of menopausal hormone treatment. Choi SD; Steinberg EM; Lee HH; Naftolin F Menopause; 2011 Feb; 18(2):230-6. PubMed ID: 21341398 [TBL] [Abstract][Full Text] [Related]
10. What the Women's Health Initiative has taught us about menopausal hormone therapy. Chester RC; Kling JM; Manson JE Clin Cardiol; 2018 Feb; 41(2):247-252. PubMed ID: 29493798 [TBL] [Abstract][Full Text] [Related]
11. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan. Huang WF; Tsai YW; Hsiao FY; Liu WC BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639 [TBL] [Abstract][Full Text] [Related]
12. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review. Fournier A Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283 [TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone treatment in postmenopausal women: risks and benefits. Dous GV; Grodman R; Mornan A; Otterbeck P; Grigos A South Med J; 2014 Nov; 107(11):689-95. PubMed ID: 25365435 [TBL] [Abstract][Full Text] [Related]
14. [Hormonal treatment for menopause and arterial risk]. Gueyffier F; Cornu C Rev Prat; 2005 Feb; 55(4):383-8. PubMed ID: 15828616 [TBL] [Abstract][Full Text] [Related]